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The current obesity epidemic in an increasingly aging 
population presents health, long-term care, and welfare 
systems with new challenges [1]. Increased 
consumption of energy-dense, nutrient-poor foods and a 
sedentary lifestyle have led to this sharp and 
unprecedented rise in the rates of overweight and 
obesity, which has been estimated to increase both 
direct and indirect health care costs due to lost 
productivity [2, 3]. Aging and excess adiposity are both 
well-established risk factors for the development and 
progression of several chronic diseases, including type 2 










































disease (CVD), osteoarthritis, depression and certain 
prevalent cancers (i.e. colon, breast, and prostate) [4]. 
The diagnosis and treatment of these common and 
preventable chronic diseases places a significant burden 
on National Health Service budgets. However, little is 
known about the true (non-estimated) impact of body 
mass index (BMI) on the inpatient and outpatient health 
care costs for these adiposity-associated chronic 
diseases. This study has several advantages over most 
existing studies. The majority of studies published so 
far have estimated the total health care costs of obesity 
by modelling group and individual level data with 
various degree of representativeness at national level, 
often relying on self-reported clinical information and 























excessive  adiposity  and  associated  age‐related  chronic  diseases.  We  used  a  prevalence‐based  approach  that  combines






in  overweight  individuals,  and  27  to  68%  greater  in  patients  with  obesity  and  very  severe  obesity,  respectively.  The
association between BMI and diabetes, hypertension and cardiovascular disease largely explained these elevated costs.  
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proxies of medical expenditures [5-11]. In this study, we 
used a patient-based approach combining health care cost 
data and accurate anthropometric and clinical 
informations collected by general practitioners in a large 
representative longitudinal sample of more than 550 
thousand Italian men and women, homogeneously 
distributed across all Italian regions. Moreover, Italy is an 
ideal setting for this type of analysis, since its National 
Health Service provides universal and substantially free 
health care access to all citizens, with 87% of medical 
services publicly financed [12], avoiding problems of 
patient selection associated with insurance based health 
care systems. Finally, by modelling this data with a 
seemingly unrelated regression equation (SURE) 
statistical method, we were able to disentangle the direct 
and indirect (i.e. obesity-associated diseases) impact of 




Sample descriptive statistics 
 
Table 1 summarizes the breakdown of the variables 
according to BMI classes, showing large differences in 
demographic and clinical parameters such as age and 
prevalence of comorbidities. Hypertension and type 2 
diabetes were the most common BMI-associated health 
conditions and their prevalence shows a strong increase 
with increasing BMI (p=0.0001 for all BMI categories 
with respect to normal weight individuals). In addition, 
the prevalence of dyslipidaemia, CVD and arthrosis 
were higher in individuals with overweight and obesity 
than in normal weight individuals in both younger (<55 
yrs) and older (>55 yrs) patients (p=0.0001 for all BMI 
categories with respect to normal weight individuals). 
There was a clear negative association between BMI 
and the proportion of individuals with no chronic 
disease (p=0.0001 for all BMI categories with respect to 
normal weight individuals).  In contrast, the proportion 
of individuals affected by 2 or more chronic diseases 
increased sharply with raising BMI.  
 
BMI and healthcare costs 
 
Table 2 and Table 3 present the coefficient estimates of 
indirect (i.e. obesity-associated diseases), direct and 
differential effects of BMI on outpatient and total health 
care costs for each age group. The tables report marginal 
effects for each BMI category within each age specific 
subsample, as well as the percentage differences of the 
marginal effect estimate with respect to the annual 
average expenditure of normo-weight individuals. 
 
As shown in Figure 1, after adjusting for age, sex, 
geographic residence, and GPs heterogeneity, there was a 
J-shaped association between BMI and overall (direct 
and indirect) total health care expenditure, which was 
stronger among middle-aged and elderly individuals. 
Total health care expenditures among the middle-aged 
(45-64 yrs old) individuals with overweight, obesity, 
severe obesity and very severe obesity were 10%, 27%, 
52% and 68% higher, respectively, than among those 
with BMI of 18.5 to 24.9 (p=0.0001) (third panel of 
Table 3). In absolute terms, outpatient costs were more 
strongly related to BMI among individuals aged 45 to 64 
years. The annual mean costs among the overweight, 
obesity, severe obesity and very severe obesity patients 
were 76, 159, 237, and 310 euro higher, respectively, 
than in normo-weight individuals, which translates in a 
cost increase of about 18%, 38%, 57% and 75% for each 
BMI category, respectively (third panel of Table 2). In 
contrast, total costs were more strongly related to BMI 
among individuals aged 65+ years. The annual 
differential mean costs among the patients with 
overweight, obesity, severe obesity and very severe 
obesity were 75, 302, 719, and 790 euro higher, 
respectively, than in normal weight individuals (fourth 
panel of Table 3). Total overall (direct and indirect) costs 
were also significantly higher in underweight individuals 
than in normal weight individuals in all subsamples 
(Table 3). In particular, annual mean total costs among all 
underweight individuals were 138 euro higher than in the 
normo-weight subjects, which translates in a cost 
increase of 13% (first panel of Table 3).  
 
Indirect and direct costs 
 
The share of indirect costs within overall outpatient 
costs was the largest in overweight and obese men and 
women aged 45-64 years (Table 2). Moreover, the 
indirect costs of the underweight subjects were lower 
than those of the normo-weight individuals for each age 
group, and this differential was more pronounced in the 
elderly, amounting to 11% (Table 2).  
 
In terms of total outpatient and inpatient health 
expenditure, direct costs were negative in the overweight 
and obesity groups, suggesting that after correcting for 
BMI-related pathologies, these patients on average had 
lower health care expenditures than normo-weight 
individuals. This direct cost differential turned positive 
for the category with severe and very severe obesity, and 
was particularly pronounced in the elderly (Table 3). 
Moreover, the total indirect costs in the underweight 
individuals were significantly lower than in the normo-
weight subjects, and this differential was particularly 
high in the elderly (fourth panel of Table 3). Finally, the 
total direct costs in the underweight men and women 
were substantially higher than in the elderly normo-
weight individuals.  
  















































































































Figure 1.  Total  (a)  and outpatient  (b) health  care  expenditure. Decomposition  of  differences  in  health  care  expenditure  (direct,
indirect and overall costs) by age group and BMI category compared to normal‐weight individuals (euro per year) for outpatient (b) and total























































































































 Under Normal Over Obesity Obesity Obesity 












       
Sample size 72032 1103594 997802 390109 105731 35943 
Mean BMI (kg/m2) 17.5* 22.3 27.2* 32* 36.9* 43.6* 
Gender (% female) 82.3%* 61.0% 44.8%* 50.2%* 62.4%* 71.7%* 
Mean age (yrs) 39* 48 56* 57* 56* 54* 
Age group (%)       
18-24 25%* 10% 3%* 2%* 2%* 3%* 
25-34 28%* 17% 8%* 7%* 7%* 8%* 
35-44 19%* 20% 15%* 14%* 14%* 15%* 
45-54 9%* 17% 19%* 19%* 20%* 21%* 
55-64 6%* 13% 21%* 24%* 25%* 26%* 
65-74 6%* 11% 19%* 21%* 21%* 19%* 
75+ 8%* 10% 14%* 14%* 12%* 8%* 
Comorbidities  (%)       
Age group under 55       
Diabetes 0.4%* 1.1% 3.5%* 7.3%* 12.1%* 16.7%* 
Hypertension 1.9%* 6.4% 17.4%* 27.8%* 36.5%* 42.5%* 
Dyslipidemia 1.9%* 5.4% 11.6%* 13.3%* 12.0%* 9.4%* 
CVD 0.2%* 0.6% 1.5%* 2.0%* 2.2%* 2.0%* 
Depression 4.7%* 4.0% 3.9%* 4.6%* 5.6%* 6.7%* 
Cancers 0.5%* 0.6% 0.6% 0.7% 0.7% 0.7% 
Arthrosis 0.9%* 1.2% 2.0%* 2.7%* 3.7%* 4.9%* 
Age group over 55       
Diabetes 5.6%* 12.5% 19.9%* 28.0%* 35.0%* 38.7%* 
Hypertension 38.9%* 49.4% 61.9%* 72.0%* 78.9%* 82.8%* 
Dyslipidemia 18.8%* 26.9% 30.3%* 29.8%* 28.0%* 23.1%* 
CVD 9.9%* 11.4% 13.9%* 14.7%* 14.6%* 12.3%* 
Depression 10.4%* 8.0% 6.7%* 7.2%* 8.1% 8.3% 
Cancer 6.5%* 6.0% 5.7%* 5.3%* 4.7%* 4.1%* 
Arthrosis 6.5%* 8.0% 10.2%* 13.1%* 15.9%* 18.0%* 
No. of comorbidities        
Age group under 55       
0 90.5%* 83.5% 68.5%* 58.1%* 50.3%* 45.4%* 
1 8.7%* 14.0% 24.0%* 29.0%* 31.8%* 33.3%* 
2 0.8%* 2.2% 6.1%* 9.9%* 13.4%* 15.5%* 
>=3 0.1%* 0.3% 1.4%* 3.1%* 4.4%* 5.8%* 
Age group over 55       
0 37.6%* 28.0% 19.3%* 13.4%* 9.9%* 8.5%* 
1 37.0% 36.6% 35.4%* 33.1%* 31.0%* 31.1%* 
2 18.4%* 23.6% 28.0%* 30.8%* 32.3%* 33.8%* 
>=3 7.1%* 11.8% 17.4%* 22.8%* 26.8%* 26.6%* 
Smokers (%) 44%* 40% 34%* 31%* 31%* 28%* 
(subsample in which 
smoking information 
was available) 
8124 138211 135669 54825 15007 5013 
* p<0.01, † p<0.05, ‡ p<0.1, each p value refers to a t test for equality of means for  each category 
with respect to normal weight category 
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Relative effects of BMI and adiposity-associated 
comorbidities on health care costs  
 
As shown in figure 1, based on SURE analysis, the 
indirect costs of excess body weight in individuals with 


















































overall BMI-related costs both in terms of outpatient 
and total health care expenditures. Moreover, as shown 
in figure 2, when hypertension, diabetes and CVD were 
accounted for, the age-adjusted relation between BMI 
and total and outpatient health care costs was to a large 























































Indirect Direct Overall 










Marginal effect % difference from the mean 
Full sample (N=2705211), average estimated expenditure = 445 euro 
Underweight -8.918*** -2% 12.66*** 3% 3.745* 1% 
Overweight 46.19*** 10% -1.650** 0% 44.54*** 10% 
Obesity 98.07*** 22% 12.51*** 3% 110.6*** 25% 
Severe obesity 139.3*** 31% 33.77*** 8% 173.0*** 39% 
Very severe obesity 159.3*** 36% 69.48*** 16% 228.7*** 51% 
18-44 (N=934147), average estimated expenditure = 173 euro 
Underweight -6.019*** -3% -8.615*** -5% -14.63*** -8% 
Overweight 18.08*** 10% 10.40*** 6% 28.48*** 17% 
Obesity 39.05*** 23% 18.44*** 11% 57.48*** 33% 
Severe obesity 63.34*** 37% 30.43*** 18% 93.76*** 54% 
Very severe obesity 91.40*** 53% 73.45*** 43% 164.8*** 95% 
45-64 (N=990831), average estimated expenditure = 416 euro 
Underweight -33.64*** -8% 30.61*** 7% -3.034 -1% 
Overweight 74.71*** 18% 1.289 0% 76.00*** 18% 
Obesity 145.1*** 35% 14.16*** 3% 159.3*** 38% 
Severe obesity 203.9*** 49% 33.27*** 8% 237.2*** 57% 
Very severe obesity 236.3*** 57% 73.93*** 18% 310.2*** 75% 
65+ (N=780233), average estimated expenditure = 796 euro 
Underweight -84.66*** -11% -0.941 0% -85.60*** -11% 
Overweight 65.49*** 8% 5.145*** 1% 70.64*** 9% 
Obesity 115.8*** 15% 25.25*** 3% 141.1*** 18% 
Severely obesity 145.9*** 18% 56.22*** 7% 202.1*** 25% 
Very severe obesity 138.3*** 17% 78.01*** 10% 216.3*** 27% 
- ***p<0.01, ** p<0.05, * p<0.1, each p value refers to a t test for equality of means for each category with respect to 
normal weight category. 
- Average estimated expenditure for each sample was obtained as the predicted expenditure from the health expenditure 
equation, calculated for the normal weight individuals, and at means of all other regressors. 
- Indirect marginal effects for each BMI category were computed as the sum of nonlinear combinations of parameters 
estimated within each pathology-specific equation with the respective pathology-specific parameter estimated within the 
health expenditure equation.  
- Direct marginal effects for each BMI category were obtained as relative parameter estimates from the health 
expenditure equation.  
- Overall marginal effects for each BMI category was computed as the sum of the respective direct and indirect marginal 
effects.  
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Full sample (N=2705211) , average estimated expenditure = 1092 euro 
Underweight -15.92*** -1% 154.0*** 14% 138.1*** 13% 
Overweight 104.0*** 10% -66.52*** -6% 37.44*** 3% 
Obesity 237.3*** 22% -43.89*** -4% 193.4*** 18% 
Severe obesity 351.2*** 32% 95.02*** 9% 446.2*** 41% 
Very severe obesity 417.1*** 38% 133.0*** 12% 550.1*** 50% 
18-44 (N=934147) , average estimated expenditure = 399 euro 
Underweight -10.23*** -3% 72.71*** 18% 62.49*** 16% 
Overweight 30.42*** 8% -8.392*** -2% 22.03*** 6% 
Obesity 66.72*** 17% 5.606** 1% 72.32*** 18% 
Severe obesity 108.8*** 27% 47.43*** 12% 156.3*** 39% 
Very severe obesity 157.3*** 39% 144.0*** 36% 301.3*** 75% 
45-64 (N=990831) , average estimated expenditure = 867 euro 
Underweight -54.25*** -6% 180.0*** 21% 125.7*** 14% 
Overweight 128.2*** 15% -45.25*** -5% 82.92*** 10% 
Obesity 257.0*** 30% -22.30*** -3% 234.7*** 27% 
Severe obesity 370.1*** 43% 82.05*** 9% 452.2*** 52% 
Very severe obesity 436.8*** 50% 156.2*** 18% 593.0*** 68% 
65+ (N=780233) , average estimated expenditure = 2193 euro 
Underweight -235.1*** -11% 468.4*** 21% 233.4*** 11% 
Overweight 202.2*** 9% -127.3*** -6% 74.87*** 3% 
Obesity 381.9*** 17% -79.79*** -4% 302.1*** 14% 
Severe obesity 504.0*** 23% 215.2*** 10% 719.3*** 33% 
Very severe obesity 524.6*** 24% 265.5*** 12% 790.1*** 36% 
- ***p<0.01, ** p<0.05, * p<0.1, each p value refers to a t test for equality of means for  each category with respect to 
normal weight category 
- Average estimated expenditure for each sample was obtained as the predicted expenditure from the health expenditure 
equation, calculated for the normal-weight individuals, and at means of all other regressors. 
- Indirect marginal effects for each BMI category were computed as the sum of nonlinear combinations of parameters 
estimated within each pathology-specific equation with the respective pathology-specific parameter estimated within 
the health expenditure equation.  
- Direct marginal effects for each BMI category were obtained as relative parameter estimates from the health 
expenditure equation.  
- Overall marginal effects for each BMI category was computed as the sum of the respective direct and indirect 
marginal effects. 
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DISCUSSION 
 
In this study, we evaluated the disease burden, and the 
direct and indirect effects of BMI on health care costs, 
in a large population of 557,145 men and women for 
whom accurate anthropometric, clinical and medical 
cost data collected by general practitioners were 
available. First, our data show a sharp increase in the 
proportion of individuals affected by 2 or more age-
associated chronic diseases with raising BMI. Second, 
our data show that after adjusting for age, sex, 
geographic residence, and GPs heterogeneity, BMI still 
has a relevant effect on both inpatient and outpatient 
health care expenditure. We found a strong J-shaped 
association between BMI and total health care costs, 
which was more pronounced in middle-aged and older 
adults. Third, our results demonstrated that 
hypertension, diabetes and CVD account for the largest 
share of outpatient and total health care expenditures. 
  
Many studies have attempted to estimate the health care 
costs attributable to excess body weight. However, most 
published studies so far have estimated BMI-related 
costs by using a top-down approach which quantifies 
attributable fractions of costs associated with adiposity-
related diseases by modelling group and individual level 
data collected from National Health interview surveys 
[5-11]. Moreover, in these studies the determinants of 
BMI and the prevalence of chronic diseases were 
mostly self-reported and, therefore, subjected to bias 
[31]. To our knowledge, this is the first study to 
determine the direct and indirect health care costs by 
using a prevalence-based approach that combines data 
from a large observational dataset, containing 
computer-based patient records with accurate 
anthropometric and clinical information and precise 
medical cost data collected by general practitioners. Our 
data are generally in line with the estimates of other 
studies [21, 22, 25]  showing that total health care 
expenditure of the overweight is around 3% higher than 
in normal weight individuals, while patients with 
obesity, severe obesity and very severe obesity spend 
respectively 18%, 41% and 50% more than their 
normal-weight counterparts. 
 
Interestingly, we found that BMI-related costs vary 
substantially across age groups. With respect to normo-
weight individuals, the highest overall (direct plus 
indirect) outpatient expenditure differentials in absolute 
terms were found in the 45-64 age group, and in the 65+ 
age group for total out- and in-patient health care costs. 
This finding suggests that outpatient health care 
utilization in terms of drugs, medical visits and diagnostic 
tests resulting from excess body weight is particularly 
higher in the 45-64 age group. However, when inpatient 
expenditure (hospitalizations) was accounted for, the 65+ 
age group patients generated in absolute terms the 
majority of the BMI related health care costs.  
 
It is essential, however, to establish the extent to which 
one or more obesity-related medical conditions may 
account for the variation in health care costs by BMI. Our 
sophisticated multivariate regression SURE analysis 
indicated that much of the increased costs can be 
attributed to three very prevalent chronic diseases: 
hypertension, type 2 diabetes and CVD. These data are in 
agreement with previous estimates of other studies [32, 
33]. However, this does not mean that BMI is not related 
to increased health care expenditure through other 
channels, because in our study individuals with severe 
and very severe obesity had high direct health care costs, 
net of the frequent adiposity-related medical conditions.  
 
The prevalence of overweight and obesity in Italy, as in 
many other developed and developing countries, has 
been increasing steadily in the last few years [1, 2, 34]. 
Our data show that the rise in body weight is associated 
with a strong increase in the prevalence of several 
chronic diseases, including type 2 diabetes, hyper-
tension, dyslipidemia, CVD, depression and arthrosis, 
especially in individuals aged 55+ years. Moreover, our 
data show that as BMI increases, the percentage of 
younger and older adults with two or more adiposity-
related medical conditions increases several fold, 
whereas the proportion of individuals with no chronic 
diseases diminishes by 2 fold in the 18 to 55-year-old 
age group and by 3 folds in individuals over 55-years-
old.  
 
The results of our study provide firm evidence that the 
impact that excess body weight has on a set of chronic 
diseases, represents the largest component of health care 
expenditures. Considering our marginal BMI-related 
costs and the official statistics of obesity prevalence of 
the Italian adult population [35], we estimated that the 
overall BMI-related costs amount approximately to 4% 
of total health care expenditure of the Italian national 
health service (i.e. 4.5 billions of euro per year). This 
estimate, based on the self- and under- reported official 
prevalence rates of BMI among the Italian population 
represents a lower bound of the real costs of excessive 
adiposity in Italy. In fact, this estimate is slightly lower 
than the 5-10% found for the USA [23, 26, 29, 30], and 
4.5% for the UK [28], while somewhat higher than 2.3-
3.5% found for Switzerland [27]. 
 
Strengths and limitations 
 
It is important to highlight the strengths and limitations 
of this study. The use of clinical data (e.g. weights, 
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heights, chronic disease diagnosis, test results, drug 
prescriptions, outpatient diagnostic tests, specialist 
visits and hospital admissions), collected for a large 
sample of patients and entered in an up-to-date 
computer-based database by trained GPs, is a major 
strength of this study. In addition, it is important to 
stress that the Italian National Health Service is a public 
and universalistic system, which provides substantially 
free health services for all citizens. According to OECD 
Health Data, in 2012 about 87% of medical services in 
Italy was publicly financed. This setting favours the 
external validity of the study and minimizes the 
selection problems related to presence of private 
insurance plans. Finally, the use of a multi-equation 
recursive model (SURE) to calculate the relative effects 
of BMI and adiposity-associated chronic diseases on 
health care costs represents another strength of this 
study, since it provides better and more efficient 
estimates of the cost of obesity and allows to study 
direct and indirect effects of BMI of health care 
expenditure. One major limitation of this study is the 
lack of alternative measures of adiposity, such as waist 
circumference or waist-hip ratio. Moreover, the analysis 
could potentially benefit by introducing covariates such 
as smoking or socio-economic status, enhancing the 
precision of the coefficient estimates, which are not 
available within this dataset. Finally, the estimates 
might suffer from a downward bias, as the control group 
includes individuals who, while not being affected by 
the diseases included in this analysis, may have had 
other pathologies, which may increase health 




Sources of data. The present analysis was based on data 
of 557,145 men and women, older than 18 years, who 
were observed at different times between 2004 and 
2010, amounting to a total of 2,705,211 observations. 
The anthropometric and clinical data have been 
extracted from the Health Search/CSD Patient Database 
(HS), an Italian general practice registry that includes 
data obtained from computer-based patient records of a 
selected group of 700 general practitioners (GP), 
homogeneously distributed across all Italian regions, 
covering a patient population of over a 1.8 million 
between 2004-2010. The GPs voluntarily agreed to 
collect patient information and to attend specific 
training courses for data entry [13]. The HS database 
contains patient demographic data that are linked 
through the use of an encrypted patient code with their 
medical records (diagnoses, prescribed tests results), 
drug prescription information (medication name, date of 
filled prescription, and number of days’ supply), 
hospital admissions, and date of death. To be considered 
for participation in epidemiological studies, GPs should 
meet “up-to-standard” quality criteria pertaining to the 
levels of coding, prevalence of well-known diseases, 
mortality rates, and years of recording [13]. The HS 
database complies with the European Union guidelines 
on the use of medical data for research, and has 
previously been demonstrated to be a valid data source 
for scientific research [14-16]. GPs collected this 
information on daily basis. However, in this study the 
records have been collapsed to obtain yearly aggregates. 
Finally, these data have been merged, at patient level, 
with data from the SiSSi (Simulazione Spesa Sanitaria 
Italiana – Simulation of the Italian Health Care 
Expenditure) project, which includes information on 
prices and tariffs for drugs, outpatient visits, diagnostic 
tests and hospitalization visits. By multiplying health 
care service utilization data from the HS with price and 
tariff data from the SiSSi project we obtained detailed 
information on public health care expenditure at the 
patient level [17-19]. 
 
Model structure. Obesity-related health care 
expenditure is generally studied with a cost-regression 
approach [20-30]. However, this method is likely to 
produce biased estimates, since it does not analyze the 
mechanisms at play between BMI and health care 
expenditures. Therefore, we have built a multi-
equation recursive model within a Seemingly 
Unrelated Regression Estimator (SURE) approach to 
quantify: (1) indirect costs, resulting from the impact 
that BMI has on a set of chronic diseases commonly 
attributable to obesity, which in turn influence health 
expenditure; and (2) direct costs, defined as the 
residual impact of BMI independent of adiposity-
associated chronic diseases, after adjusting for age, 
sex, geographic residence, and GPs heterogeneity. The 
statistical model consisted of eight equations, 
estimated simultaneously, of which the first 7 
represent the sets of obesity-related chronic diseases 
(1) type 2 diabetes mellitus; (2) hypertension; (3) 
dyslipidemia; (4) cardiovascular diseases: coronary 
artery disease, ischemic stroke, congestive heart 
failure; (5) cancers: breast, colon, and prostate cancer, 
(6) arthrosis: hip and knee arthrosis; (7) depression, 
while the last equation modeled the health care 
expenditure as a function of the above chronic 
conditions plus BMI.  
 
Dependent variables. The empirical model comprised 8 
equations, and hence there were 8 dependent variables: 
7 dummy variables indicating the presence of one of the 
selected diseases at patient level plus the per-capita 
health care expenditure variable. We used two 
definitions of health expenditure: “outpatient” health 
care expenditure and “total” health care expenditure (i.e. 
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inpatient and outpatient medical costs). Precise data on 
health care expenditure were obtained from a merge of 
Health Search CSD-LPD database with data on costs 
and tariffs of drugs, outpatient visits, diagnostic tests, 
and hospitalizations from the SiSSI Project. 
Furthermore, since the Health Search CSD-LPD PCP’s 
may underreport the events of hospital admissions, we 
reweighted the Health Search CSD-LPD hospitalization 
rates with the hospital admission data collected by the 
Italian National Institute of Statistics (ISTAT). The 
weighting procedure stratifies the patient population by 
region, age (18-44, 45-64 and 65 and older), gender and 
BMI level in order to match cell groups of individuals 
in the Health Search CSD-LPD and ISTAT datasets. 
Subsequently, average hospitalization costs for the same 
cell groups were computed from the Hospital Discharge 
dataset of the Italian Ministry of Health and assigned to 
the Health Search CSD-LPD population.  
 
Covariates. BMI was calculated as weight in kilograms 
divided by the square of height in meters. Study 
participants were divided in 6 groups with: normal 
weight (BMI, 18.5-24.99 [the reference group]), 
underweight (BMI between 15 and 18.49), overweight 
(BMI, 25.0-29.99), obesity (BMI, 30.0-34.99), severe 
obesity (BMI, 35.0-39.99) or very severe obesity (BMI 
>40.0). Since health expenditure may differ due to GPs 
practice heterogeneity, we controlled for GPs behavior, 
including variables such as the average number of 
patient contacts, the average number of prevention 
visits, the number of overall patients registered with the 
GPs practice and the average unit price of the 
prescribed drugs. Finally, we accounted for patient 
heterogeneity by controlling for age, gender, and region 
of residence.  
 
Statistical analysis. In econometrics, the seemingly 
unrelated regression equations (SURE) model is a 
generalization of a linear regression model that consists 
of several regression equations, each having its own 
dependent variable and potentially different sets of 
exogenous explanatory variables [20]. Analytically, the 
structure of a SURE model employed in this analysis 
can be represented by the following 8 equation model: 
  
Pjit = αj0 + βj  BMI it-1 + δj X it + θj GPit + ε jit 
 
HEit = θ0 + ∑7j=1λj Pjit + π BMI it-1  + ρ X it  + σ GPit  + ηit 
 
where j = 1,..,7 represents the sets of pathologies, i 
stands for individuals, t =2004,...,2010 for years, and 
where P is the set of seven pathologies’ indicator 
dummy variables, HE denotes health expenditure in 
euro per year, BMI is the vector of body weight dummy 
variables categories observed in the year preceding the 
diagnosis of pathologies and health expenditure 
realization; X is a set of control variables including age, 
gender, region of residence and year time dummies; and 
GP is a vector of variables including physician 
characteristics. Finally, εjit and ηit are idiosincratic error 
terms. The assumption of the model is that error terms 
are independent across time, but may have cross-
equation contemporaneous correlations. Thus we 
assume that E[ εir εis | X ] = 0 whenever r ≠ s, whereas 
E[ εir εjr | X ] = σij. Although Ordinary Least Squares 
(OLS) estimate of our model parameters are consistent, 
generally they are not as efficient as the SURE method, 
which uses the feasible generalized least squares 
(FGLS) method with a specific form of the variance-
covariance matrix. The analysis was conducted 
separately for the whole sample of patients as well as 
for subsamples by age classes (18-44 year olds, 45-64 
year olds and 65+ year olds). The coefficient estimates 
were expressed as marginal effects. For the full sample, 
the reference category was a male, resident of the 
Piedmont region in North Italy, in the normal weight 
BMI category, not affected by any of the pathologies 
considered in the study, observed for the first time in 
2004 and aged between 18 and 44. This last condition 
was not considered when dealing with the subsamples 
by ages. The parameter estimates described the impact 
of each covariate on individual health care expenditure. 
The statistical analysis was performed using Stata 




Based on one of the largest datasets used in this 
literature, the results of this study reinforce the 
concept that overweight and obesity increases the risk 
of developing multiple and costly chronic diseases. 
Our findings demonstrate the adverse impact of 
increased BMI on outpatient and total healthcare costs, 
especially in middle-aged and elderly individuals. 
They also show that hypertension, type 2 diabetes and 
CVD are responsible for a large part of these BMI-
related health care expenditures. The knowledge of 
these costs will be useful for future economic analysis 
of preventive and treatment interventions, such as 
long-term, comprehensive national initiatives that 
tackle the basic causes of poor diet quality and 




Supported in part by the Italian National Institute of 
Health (ISS), Rome, Italy. ISS had no involvement in 
the design of the study, collection, analysis, or 
interpretation of the data, nor decision to approve 
publication of the finished manuscript.  
  
www.impactaging.com                   891                                   AGING, October 2015, Vol. 7 No.10
 
Conflict of interest statement 
 




1.  Finucane  MM,  Stevens  GA,  Cowan  MJ,  Danaei  G,  Lin  JK, 
Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar 
F, Riley LM, Ezzati M, et al. National, regional, and global trends 
in  body‐mass  index  since  1980:  systematic  analysis  of  health 
examination  surveys  and  epidemiological  studies  with  960 






HH.  Economic  costs of overweight  and obesity. Best Pract Res 
Clin Endocrinol Metab. 2013; 27:105‐115. 


















12.  OECD.  1913.    Health  at  a  Glance  2013:  OECD  Indicators: 
OECD Publishing. 
13. Lawrenson R, Williams T and Farmer R. Clinical  information 






15.  Mazzaglia  G,  Ambrosioni  E,  Alacqua  M,  Filippi  A,  Sessa  E, 










primary  care  costs:  the  Italian  experience.  Soc  Sci Med.  2014; 
114:10‐17. 
18. Atella V and Kopinska JA. The impact of cost‐sharing schemes 












22. Andreyeva T,  Sturm R and Ringel  JS. Moderate and  severe 
obesity  have  large  differences  in  health  care  costs. Obes  Res. 
2004; 12:1936‐1943. 
23. Finkelstein EA, Trogdon  JG, Cohen  JW and Dietz W. Annual 
medical  spending  attributable  to  obesity:  payer‐and  service‐
specific estimates. Health Aff. 2009; 28:w822‐831. 
24. Bahia L, Coutinho ES, Barufaldi LA, Abreu Gde A, Malhao TA, 
de  Souza  CP  and  Araujo  DV.  The  costs  of  overweight  and 
obesity‐related  diseases  in  the  Brazilian  public  health  system: 
cross‐sectional study. BMC public health. 2012; 12:440. 
25.  Cawley  J  and  Meyerhoefer  C.  The  medical  care  costs  of 





27.  Schmid  A,  Schneider  H,  Golay  A  and  Keller  U.  Economic 
burden  of  obesity  and  its  comorbidities  in  Switzerland.  Soz 
Praventivmed. 2005; 50:87‐94. 





overweight  and  obesity  in  the  USA:  a  quantitative  systematic 
review. Obes Rev. 2011; 12:50‐61. 
31. Harlow SD and Linet MS. Agreement between questionnaire 






WH.  The  disease  burden  associated  with  overweight  and 
obesity. Jama. 1999; 282:1523‐1529. 
34.  Devaux  M  and  Sassi  F.  Social  inequalities  in  obesity  and 
overweight  in  11  OECD  countries.  Eur  J  Public  Health.  2013; 
23:464‐469. 







www.impactaging.com                    892                                   AGING, October 2015,  Vol.7 No.10
